Find Nonprofit and Small Business Grants

Advance Search

Only Available for Paid Subscribers
Clear Filters
Search Filters

Alkermes Pathways Research Awards

Grants to USA Early Career Investigators for Research Projects
Related to Schizophrenia and Substance Abuse Disorders

Agency Type:

Foundation / Corporation

Funding Source:

Add to My Calendar 

Alkermes

Deadline Date:

07/31/19 11:59 PM EDT

Description:

Request a Grant Writer

Grants to USA early career investigators for research projects focusing on schizophrenia or substance use disorders. The purpose of the program is to advance the awareness and understanding of central nervous system disorders and to help patients that are affected by them.

2019 Areas of Interest:

Substance Use Disorder (SUD):
- Research on SUD treatment, management, and prevention
- Research on SUD and its complications in special populations
- Preclinical, clinical, translational, and epidemiological research related to SUD
- Short-term and long-term economic and clinical outcomes using real-world data in SUDs

Schizophrenia:
- Research on assessment methods addressing barriers to optimal outcomes for persons with schizophrenia
- Research on patient-centered outcomes
- Preclinical and translational research related to the pathophysiology of schizophrenia or its treatment
- Health economic outcomes research related to schizophrenia

Projects should yield results that merit submission as abstracts to scientific meetings and, subsequently, publication in peer-reviewed journals.

Funds may be used for:
- Personnel necessary to complete the project. This cost may not exceed 50% of the direct cost.
- Funding for hours of work, which are specified in the research project.
- Supplies and consumables necessary to fulfill the research project’s aims.
- Travel to a scientific meeting for the presentation of data from the project may be included. This may be up to $1,500.
- Overhead costs (Additional documentation is required for overhead costs greater than 30% for clinical projects and greater than 50% for non-clinical projects).

GrantWatch ID#:

GrantWatch ID#: 186086

Number of Grants:

Alkermes has reserved 4 awards for the SUDs program and 4 for the schizophrenia program.

Estimated Size of Grant:

Up to $100,000 per project

Term of Contract:

The duration of the grant will be 2 years. Each grant is non-renewable.

Additional Eligibility Criteria:

This grant is for investigators who are in the early stages of their career; specifically, they may be the recipient of a career development (K) award or other mentored research grants, but not a funded R01 grant or equivalent at the time of application.

Researchers with an academic position above assistant professor are not eligible.

Alkermes Pathways Research Awards program grants will be awarded to researchers who have demonstrated a commitment to SUD or schizophrenia research. Eligible applicants must meet the following criteria:

- Have an MD, PhD, or equivalent
- Affiliated with a medical or research center within the United States at the time of application
- Within 5 years of initial academic appointment (e.g., assistant professor) or current postdoctoral fellow
- Research focuses primarily on furthering knowledge of SUDs or schizophrenia
- Have a research mentor with extensive experience in the field of SUDs or schizophrenia
- Have not received an NIH R01 grant at the time of award
- Able to complete the proposed research within 2 years
- Citizen or permanent resident of the United States or hold a temporary non-immigrant visa that is valid for the duration of the 2-year grant period

Funds may not be used for any expenses unrelated to the research project, including equipment, office supplies, tuition, fees, dues, subscriptions, and salary or travel expenses related to other projects.

If Alkermes drug is requested and is available, it will be provided at no cost in a sufficient quantity to complete the research project. Alkermes will not provide funding to purchase Alkermes drug.

Pathways Research Awards program grants cannot be provided to studies that are already in progress.

Pre-Application Information:

All applications, regardless of area of interest, should be submitted by email.

Application Deadline – July 31, 2019 (by 11:59 pm Eastern Daylight Time)
Notification of Review Committee Decision – November 2019
Public Announcement of Awardees – Quarter 1, 2020

Note that applications are not required to include an Alkermes product.

Total budget should not exceed $100,000, including direct study-related costs and institutional overhead.

Applications should show the commitment and ability to follow local and international requirements as applicable. For details, see http://www.alkermes.com/assets/content/files/Pathways%20Guidance_20May2019.pdf#page=3.

Grants will be awarded to each grantee’s institution. Grants distributed under this program may not have industry funding or duplicate funding from any other source, including government or nongovernmental sources. To avoid overlap with a Pathways Research Award, no other government, nongovernmental, or industry-sponsored projects may cover the same work scope as that for which funding is requested in the application to the Pathways Research Award program. However, a Pathways Research Awards program grant may be related to other funding from foundations or government agencies, as long as there is no direct overlap.

Contact Information:

Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.

Submit applications to applications@PathwaysResearchAwards.com.

If you require clarification of any information, contact the Pathway Research Awards Program Manager by the email info@PathwaysResearchAwards.com.

URL for Full Text (RFP):

Geographic Focus:

USA: Alabama;   Alaska;   Arizona;   Arkansas;   California;   Colorado;   Connecticut;   Delaware;   Florida;   Georgia;   Hawaii;   Idaho;   Illinois;   Indiana;   Iowa;   Kansas;   Kentucky;   Louisiana;   Maine;   Maryland;   Massachusetts;   Michigan;   Minnesota;   Mississippi;   Missouri;   Montana;   Nebraska;   Nevada;   New Hampshire;   New Jersey;   New Mexico;   New York City;   New York;   North Carolina;   North Dakota;   Ohio;   Oklahoma;   Oregon;   Pennsylvania;   Rhode Island;   South Carolina;   South Dakota;   Tennessee;   Texas;   Utah;   Vermont;   Virginia;   Washington, DC;   Washington;   West Virginia;   Wisconsin;   Wyoming